Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,800
Closed -$8.66M 67
2025
Q2
$8.66M Sell
10,800
-17,800
-62% -$12.8M 0.21% 124
2025
Q1
$19M Buy
28,600
+11,700
+69% +$8.51M 0.48% 40
2024
Q4
$11.7M Buy
16,900
+3,300
+24% +$2.37M 0.84% 33
2024
Q3
$11.3M Buy
13,600
+5,500
+68% +$4.92M 0.32% 84
2024
Q2
$8.28M Buy
8,100
+1,200
+17% +$1.15M 0.29% 108
2024
Q1
$6.7M Buy
6,900
+2,400
+53% +$2.13M 0.28% 112
2023
Q4
$3.41M Sell
4,500
-1,300
-22% -$858K 0.29% 78
2023
Q3
$3.41M Buy
5,800
+1,300
+29% +$863K 0.16% 129
2023
Q2
$3.26M Buy
4,500
+1,000
+29% +$680K 0.18% 127
2023
Q1
$2.38M Buy
+3,500
New +$2.25M 0.12% 142

Other funds holding ASML

Garda Capital Partners's ASML Position: Q2 2025 in Review

Garda Capital Partners sold out of ASML (ASML) in Q2 2025, closing a stake of 8,353 shares — an estimated $5.99M sold.

Garda Capital Partners first reported a position in ASML in Q3 2023 and held it in 4 quarters. The position peaked at $5.53M in Q1 2025. 1,713 funds tracked by Wall St. Rank hold ASML as of Q2 2025.

  • Garda Capital Partners reported no remaining ASML position as of Q2 2025 after selling out during the quarter.
  • Garda Capital Partners sold 8,353 ASML shares in Q2 2025, an estimated $5.99M.
  • Garda Capital Partners first reported a position in ASML in Q3 2023 and held it in 4 quarters.
  • Garda Capital Partners's ASML position peaked at $5.53M in Q1 2025.
  • 1,713 funds tracked by Wall St. Rank held ASML as of Q2 2025.

Based on Garda Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.